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ABSTRACT

COMPUTER SIMULATION OF CEREBROVASCULAR CIRCULATION.
ASSESSMENT OF INTRACRANIAL HEMODYNAMICS DURING
INDUCTION OF ANESTHESIA.

by
Steven D. Wolk

The purpose of this project was to develop a computer model of cerebrovascular
hemodynamics interacting with a pharmacokinetic drug model to examine the effects of
various stimuli during anesthesia on cerebral blood flow and intracranial pressure.
The mathematical model of intracranial hemodynamics is a seven compartment
constant volume system. A series of resistances relate blood and cerebrospinal fluid
fluxes to pressure gradients between compartments. Arterial, venous, and tissue
compliance are also included. Autoregulation is modeled by transmural pressure
dependent arterial-arteriolar resistance.

The effect of a drug (thiopental) on

cerebrovascular circulation was simulated by a variable arteriolar-capillary resistance.
Thiopental concentration, in turn, was predicted by a three-compartment
pharmacokinetic model. The effect site compartment was included to account for a
disequilibrium between drug plasma and biophase concentrations. The model was
validated by comparing simulation results with available experimental observations. The
simulation program is written in VisSiM® dynamic simulation language for an IBMcompatible PC.

The model developed was used to calculate cerebral blood flow and intracranial
pressure changes which occur during the induction phase of general anesthesia.
Responses to laryngoscopy and intubation were predicted for simulated patients with
elevated intracranial pressure and nonautoregulated cerebral circulation. Simulation
shows that the induction dose of thiopental reduces intracranial pressure up to 15%. The
duration of this effect is limited to less than three minutes by rapid redistribution of
thiopental and cerebral autoregulation.

Subsequent laryngoscopy causes acute

intracranial hypertension exceeding the initial intracranial pressure. Further simulation
predicts that this untoward effect can be minimized by an additional dose of thiopental
administered immediately prior to intubation.
The presented simulation allows comparison of various drug administration schedules
to control intracranial pressure and preserve cerebral blood flow during induction of
anesthesia. The model developed can be extended to analyze more complex
intraoperative events by adding new submodels.
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CHAPTER 1
INTRODUCTION

Quantitative understanding of how hemodynamic changes influence cerebrovascular
responses in neurosurgical patients is essential to prevent untoward changes in
intracranial pressure (ICP) and cerebral perfusion pressure (CPP). This information is
usually obtained from studies in which all variables except the one under investigation
are controlled. During administration of anesthesia, however, multiple pharmacological
and mechanical interventions may take place simultaneously. The resultant effect of
these manipulations on cerebrovascular hemodynamics is difficult to predict despite an
abundance of detailed information about mechanisms of drug actions. In other words,
there are large number of analytical investigations but a scarcity of significant synthetic
studies at present. A computer model of the cerebrovascular circulation combined with a
pharmacokinetic and pharmacodynamic model of a particular drug is a method which
potentially allows systematic examination of the whole system.
The aim of this study is to develop a model of cerebrovascular circulation which
interfaces with a pharmacokinetic drug model. This objective requires linking of blood
flow and drug distribution kinetics, and is used in anesthesia simulators and studies of the
cardiovascular system [1-5]. The model developed can simulate the effects of drug(s) on
intracranial hemodynamics. The changes in cerebral blood flow (CBF) and 1CP were
calculated during induction of general anesthesia.

Hemodynamic responses to

laryngoscopy and endotracheal intubation were predicted for simulated patients with
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autoregulated and non-autoregulated cerebral circulations. Because thiopental is a
widely used and extensively studied induction agent in neuroanesthesia, it was chosen as
the sole induction agent in our analysis in order to validate the simulation. Computed
results were then compared to available experimental data. The model was also used to
suggest a drug administration regimen which minimized intracranial pressure increases
associated with endotracheal stimulation.

CHAPTER 2
MODEL DEVELOPMENT

The overall simulation program structure is shown in Figure I . The sub-model of the
cerebrovascular system was constructed using a lumped-parameter method, in which the
variables (e.g. pressure, flow, etc.) are assumed to be uniform within defined zones or
control volumes. This approach is widely used in modeling physiological systems [6-9].
It enables prediction of average trends and responses of the system when subjected to
pressure and flow perturbations.

The other submodel is a three-compartment

pharmacokinetic model of thiopental transport and metabolism linked to the biophase
compartment by the first order rate process. Thiopental primarily affects mean systemic
arterial pressure which secondarily influences CBF and ICP. This is used as an input
parameter to the cerebrovascular circulation sub-model. Action of the pharmacokinetic
model on hemodynamic model also occurs through regulation of the drug concentration
dependent arteriolar-capillary resistance. The model developed does not include the
effect of hemodynamic perturbations on pharmacokinetic parameters.

3
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Figure 1 Overall structure of the model. κ12, κ21, κ13, κ 31 = first-order, inter-compartment
rate constants; K10 =first-order elimination constant; Keo= first-order equilibrium constant
between central and effect site compartments; Ce = apparent thiopental concentration at the
effect site; Pa, Par = arterial and arteriolar pressures; Pc, Pv = capillary and cerebral venous
pressures; Pvs = venous sinus pressure; P, = central venous pressure; Caf, Cvf = cerebral
arterial and venous compliances; Cr = brain tissue compliance; Cve = extracranial venous
compliance; Raar = variable arterial-arteriolar resistance (transmural pressure-dependent); Rarc
= arteriolar-capillary resistance (thiopental concentration dependent); Rev,
R Rvvs = capillaryfvs
venous system-venous sinuses resistance; Ref,
= resistance to cerebrospinal fluid
formation and cerebrospinal fluid outflow; Rvsce = resistance to the extracranial venous
outflow.

2.1 Intracranial Hemodynamics Model
During the last decade various biophysical and mathematical models of intracranial
hemodynamics have been developed [9-15]. Depending on the aim of the study, authors
focused their attention on a particular aspect of CBF or CSF dynamics. The most
complete model of cerebral circulation was formulated by Ursino [15,16]. The unique
aspect of this model is its ability to combine many specific attributes of cerebral
hemodynamics. In particular it includes CBF autoregulation, simulates CSF formation
rate as a function of transmural pressure, and calculates model parameters using
physiological and recent anatomical data. A modified version of this model was used in
our simulation. Modification of the original model was required to introduce drug
concentration dependent parameters to predict system behavior in clinical situation.
The equations and parameters for the intracranial hemodynamics model are presented in
detail and are justified in the original articles [15,17]. Only general principles and our
modifications will be discussed in this paper. In its present form the model is a constant
volume system consisting of seven compartments: cerebrovascular arterial and arteriolar
beds, intracranial capillary compartment, venous vascular bed, venous sinuses,
cerebrospinal fluid compartment (brain tissue), and a central venous compartment. The
behavior of each compartment is represented by a single pressure value and by values of
mass flux exchanged with adjacent compartments. A series of resistances relate blood
and CSF fluxes to the pressure gradient between compartments:
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where Vn is the volume of compartment n surrounded by m compartments, qmn denotes
the flux between compartments in and

n,

(Pm - Pn) is the pressure difference between the

n-th and m-th compartment, and Rmn is the resistance of the compartmental boundary.
CSF production is directly proportional to capillary transmural pressure and inversely
proportional to choroid plexus resistance to CSF secretion. CSF re-absorption depends
on the difference between CSF and dural sinus pressure and is inversely related to
arachnoid viii resistance to fluid flow. Temporal changes of cerebral arterial and venous
blood volumes are taken into account with the two lumped parameters, arterial and
venous compliance. An exponential pressure-volume relationship has been assumed.
This implies that compliances of these compartments are inversely proportional to the
corresponding value of distending pressure where Cai and Cvi are arterial and venous
compliances respectively, Ka and Kv arterial and venous elastance coefficients; values
for these parameters were computed based on anatomical data on major human
intracranial vessels. Pa, Pic, P v are pressures in arterial, intracranial, and venous
compartments respectively. Pvi denotes the transmural pressure value at which the large
cerebral veins would collapse.

7
Compliance of cerebral tissue is described by the following equation:

where Ke is an elastance of cerebral tissue and P1 is a constant. According to this
equation tissue compliance is fairly linear at low ICP, but decreases dramatically as
intracranial pressure increases (quadratic term in the equation become relevant).
Detailed explanations and derivations describing the pressure dependency of arterial,
venous, and cerebral tissue compartments are presented elsewhere [15].
Differential equations describing intracranial dynamics can be written by imposing a
mass balance for each compartment. Compact form of these equations for all cells is:

where Cmn(Pm, Pn) is the pressure dependent compliance of the nth compartment.
The constancy of intracranial volume (Monro-Kelly principle) is expressed by the
following equation:

where Q denotes rate at which the CSF compartment can expand. This can be used to
simulate the injection of liquid into the CSF space ( used clinically to test intracranial
compliance in neurosurgical practice) as well as certain pathologic conditions (e.g.
subarachnoid hemorrhage).

8
Cerebral autoregulation is represented by a transmural pressure dependent arterialarteriolar cerebrovascular conductance.

In the original model, an S-shaped

autoregulatory curve was assumed and simulated using characteristics of the arctangent
function. The regulatory mechanism gain is an argument in the equation. The gain, in
turn, was determined by solution of a first order differential equation which includes a
time constant and a perfusion pressure percent change. This allows study of the partially
autoregulated circulation by changing equation parameters. Although satisfactory for
theoretical analysis of cerebrovascular physiology, the resulting autoregulatory curve
correlates poorly with the well described cerebral blood flow vs arterial pressure
relationship based on experimental measurements in humans reported in numerous
publications [18-20]. The data from [20] were used in our model to develop a table
function of arterial-arteriolar conductances (inverse of resistance) vs transmural pressures
across arterial wall. Figure 2 shows calculated conductances that were used in the
present model. The shape of the curve is consistent with experimentally observed
changes in autoregulatory resistance [19]. During the computational cycle the program
chooses a conductance corresponding to the transmural pressure value at any given time.
A six second time delay following a step change in arterial blood pressure was
introduced to reflect the dynamic nature of the autoregulatory response, as was
experimentally determined by Aaslid, et al.[21].

9

Figure 2 Variations of arterial -arteriolar conductance (Ga-ar)
Ga-ar with blood pressure;
is
calculated from cerebral blood flow versus mean arterial pressure data reported by Harper
and McCulloch [20]

Figure 3 compares autoregulatory curves generated by the original model, by our
modification, and experimental points from several studies reported by Lassen [18].
A table function describes only one autoregulatory curve. It lacks the flexibility of
differential equation in constructing a series of partially autoregulated curves offered by
the original model. Our choice of a table function was dictated by poor correlation of the
equation generated curve with experimental data and an inability to find an experimental
verification of partial autoregulation. The absence of autoregulation in our model was
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studied by assuming fixed arterial-arteriolar conductance (conductance at mean arterial
pressure of 100 mmHg) at all pressures.

Figure 3 Autoregulatory curves predicted by the present model and calculated using
solution of differential equations as described by Ursino [15]. Experimental points are from
Lassen [18]. Mean values of 9 groups of subjects have been plotted.

The effect of thiopental on cerebrovascular circulation was simulated by a
concentration dependent arteriolar-capillary resistance. Postulating that this resistance is
the only site of thiopental action in the brain, the model can be used to develop a
conductance (reverse of resistance) versus concentration function from experimental data

11

relating thiopental concentration and CBF [22]. Calculated conductance values were
regressed using exponential equation:

where x is thiopental concentration in ptg/mL. Product moment correlation coefficient
for this equation, r, equals 0.95.
Following a bolus intravenous injection, thiopental decreases systemic arterial
pressure by reducing cardiac output and by venodilation [23]. Experimental data from
several investigations studying the cardiovascular effects of thiopental during induction
of anesthesia, were regressed to develop a relationship between thiopental concentration
and mean systemic arterial pressure:

where x is thiopental concentration in µg/mL and MAP is mean arterial pressure in
=
mmHg.
There is good correlation between experimental data and the above equation (r
0.96).

2.2 Pharmacokinetic Model
The three compartment model was used to calculate plasma concentration of thiopental at
various times. Pharmacokinetic parameters reported by Stanski et al. [25] were used in
our simulation. Plasma concentration was linked to the apparent effect-site concentration

with a first-order rate constant, Ke0. Effect-compartment was introduced to account for
temporal dissociation between serum (central compartment), thiopental concentration and
EEG effect. Numeric integration of the system of three linear differential equations can
predict plasma concentration of thiopental following bolus injection. However, the
simulation language structure used to solve the model equations (VisSim®) does not
permit interruption of the numerical integration when the additional drug boluses are
studied. To simulate a clinical setting when two or more injections are required, an
analytical solution of the system of three linear differential equations proposed by Hull et
al. [26] was used in our model. The solution allows simulation of multiple injections as
well as the continuous infusion of drug [27].

2.3 Operation of the Computer Model
The simulation program was written in VisSim®, a simulation programming language for
an IBM compatible PC. In VisSim®, models are constructed in the form of block
diagrams. Each interconnected block represents and describes a portion of the system.
The specifics of programming using block diagram languages are discussed by
Karayanakis [28]. Fourth-order Runge-Kutta integration blocks with a time interval of
50 msec were chosen for a solution of the model equations. A 32-bit PC microcomputer
was used to realize real-time simulation.

CHAPTER 3

RESULTS

Simulation results include computation of cerebral blood flow as a function of mean
arterial pressure at different intracranial pressures and prediction of cerebrovascular
responses during the induction phase of general anesthesia. Changes in cerebral blood
flow and intracranial pressure are calculated for simulated patients with and without
autoregulation. The predictions of the model are compared with available experimental
data.

Figure 4 Cerebral blood flow as a function of cerebral perfusion pressure and intracranial
pressure (10, 30 and 50 mmHg); it is assumed that autoregulation is intact at all times.
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3.1 Effect of ICP on CBF
Figure 4 compares CBF calculated for MAP up to 170 mmHg for simulated patients with
ICP of 10, 30, and 50 mmHg. The model predicts that an ICP increase shifts the
autoregulatory curve to the right. A higher cerebral perfusion pressure is required to
maintain cerebral blood flow in these patients. ICP elevation was accomplished by
increasing resistance to CSF re-absorption. The original model used liquid bolus injected
into the CSF space to simulate intracranial hypertension. This results in a transient
response and could not be used for our simulation.
Autoregulation is modified or impaired in areas surrounding a space occupying,
traumatic, or inflammatory lesion and may be completely lost in severe head injury
[18,29]. Loss of autoregulation may leave surviving brain tissue unprotected against the
potentially deleterious effects of significant blood pressure changes. Figure 5 shows that
absence of autoregulation results in a passive CBF increase if systemic blood pressure is
increased. Sengupta et al. [30] demonstrated a similar relationship between MAP and
CBF in primates with compromised cerebral circulation. Intracranial hypertension
reduces transmural pressure and increases vascular resistance. This is reflected in a
decreased slope of CBF versus ICP with the elevation of ICP.

3.2 Clinical Applications
The induction of general anesthesia was modeled using a bolus thiopental injection
followed by laryngoscopy and incubation. ICP and CBF changes were compared for
cerebral circulation with intact and compromised autoregulation. Simulation is initiated
by injecting a typical induction dose of thiopental (5 mg/kg). It is assumed that a
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hemodynamically stable nondepolarizing neuromuscular agent is administered essentially
at the same time (e.g. vecuronium). Under normal conditions hemodynamically stable
relaxants do not alter CBF or 1CP and their influence on intracranial hemodynamics is
expressed primarily by determining a time for laryngoscopy and intubation
(approximately two minutes).

Figure 5 Cerebral blood flow as a function of cerebral perfusion pressure in nonautoregulated cerebral circulation.

Laryngoscopy and tracheal intubation are associated with sympathetic discharge
which may lead to a hypertensive response [31,32]. If thiopental is used as the sole
induction agent, endotracheal stimulation may increase MAP by 35 ± 10 mmHg
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compared to preinduction values and by 60 ± 20 mmHg compared to preintubation
values [33,34]. In our model, systemic hypertension was simulated by adding 60 mmHg
to the value of MAP 120 seconds following the induction dose of thiopental, Stimulation
persisted for 30 seconds.

Figure 6 Changes in intracranial pressure during induction of anesthesia in a simulated
patient with intact autoregulation; A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy
begins.

ICP and CBF changes during induction of anesthesia were computed for initial ICP
values of 10, 30 and 50 mmHg. Figure 6 shows that an induction dose of thiopental
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decreases ICP. The model predicts that ICP reduction is more pronounced in patients
with increased intracranial pressure (7% for patients with ICP of 10 mmHg and 15% for
patients with ICP of 50 mmHg). This effect, however, lasts less than three minutes.
Autoregulation and rapid redistribution of thiopental resulting in systemic pressure rise
lead to ICP elevation almost to preinduction level. Subsequent laryngeal stimulation
raises ICP by 5 mmHg.

Figure 7 Changes in intracranial pressure during induction of anesthesia in simulated
patient without autoregulation: A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy
begins.
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Figure 7 shows simulated ICP changes after a thiopental bolus and endotracheal
intubation in a patient without autoregulation.

Simulation demonstrates that

laryngoscopy and endotracheal intubation may dangerously increase ICP by an additional
14 and 26 mmHg in compromised patients whose intracranial pressure begins at 30 and
50 mmHg, respectively. The duration of ICP increase is deteiniined by the length of
laryngeal stimulation (30 seconds in our simulation).

Figure 8 Changes in cerebral blood flow during induction of anesthesia in a simulated
patient with intact autoregulation: A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy
begins.
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Figure 9 Changes in cerebral blood flow during induction of anesthesia in a simulated
patient without autoregulation; A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy
begins.

Figures 8 and 9 show simulated CBF changes during induction of general anesthesia
with thiopental for patients with and without cerebral autoregulation. Similar to 1CP
responses, CBF changes are exaggerated in simulated patients with increased 1CP and no
autoregulation.

CHAPTER 4

DISCUSSION

The mathematical model described in this paper is being developed to simulate clinical
behavior of the cerebrovascular circulation. The model is constructed by connecting submodels of intracranial hemodynamics and drug pharmacokinetics. The complexity of the
model can be reduced by using a multiple modeling technique. Simplification is
achieved by setting up and testing individual units separately and then combining them
into a complete model [35,36]. The modular approach also allows addition of new units
to the model as needed. The multiple modeling technique is used to study performance
of systems with two or more kinds of transport (e.g. momentum, mass, etc.) taking place
simultaneously [2,3,5,37].
In building a model a compromise must be made between model simplicity and
accuracy of results. Approximations and assumptions are always involved. This model
was developed to study the effect of phaimacologic and mechanical intervention on the
cerebrovascular circulation during administration of anesthesia.

Three sets of

assumptions were used: assumptions related to development of the intracranial
hemodynamic model, assumptions related to pharmacokinetics of thiopental, and
assumptions concerning the simulated example - induction of anesthesia with thiopental.
Limitations related to these assumptions should be evaluated in order to appreciate the
results of the simulation.

20
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4.1 Circulation Model Limitations
The lumped parameter model of cerebral circulation was constructed by grouping
cerebral vessels and brain parenchyma into distinct functional compartments. The
equations that ensue are linear ordinary differential equations (as opposed to partial
differential equations for distributed systems). This method does not allow evaluation of
the relative role of different cerebral regions in regulation of blood flow. Consequently
pathologic conditions which are associated with regional CBF differences (cerebral
ischemia, steal phenomena, etc.) can not be studied with this model in its present form.
Including the arteriolar compartment and thiopental dependent resistance was
necessary to study the effects of drug concentration on intracranial hemodynamics. A
dose-dependent reduction of metabolism (CMRO2) with thiopental administration in
humans and animal experiments is well documented [20,38,39]. Functional depression
of brain activity leads to a corresponding CBF decrease. Although the exact mechanism
linking flow and metabolism is unclear, it appears that coupling occurs at the level of
small arterioles [40]. Thus, arteriolar-capillary resistance was chosen as the model site of
thiopental action.
The goal of any particular study deteimines the degree of simplification necessary.
Metabolic and respiratory factors have been omitted, although they can be added in
modules as needed. The level Of CO2, H', and 02 profoundly affect CBF and ICP, but it
was assumed that these parameters were unchanged in order to compare the effects of
thiopental administration and intubation under various simulated clinical situations.
Simple "experimental" design was necessary at the initial stage of model development to
validate simulated results with the available clinical observations.
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Our model includes intracranial arterial, venous, and tissue compliances. Pressure
difference between adjacent compartments and elastance coefficients determines their
numerical values. Although it is very likely that elastance coefficients would be affected
by thiopental concentration, there is no experimental verification of this relationship.
Thus, only the effect of pressure changes on compliance is included in the model.
1CP elevation in our simulation was accomplished by increasing a resistance to CSF
re-absorption. Intracranial hypertension can be produced also by increasing the brain
tissue elastance coefficient. Comparison of the various ways of decreasing intracranial
compliance and examination of compliance changes on cerebral blood flow and
intracranial pressure was not part of this study, but will be addressed in the future.

4.2 Limitations of Pharmacokinetic Model
Rigorous determination of thiopental uptake by brain tissue requires knowledge of
cerebral blood flow, volume, and blood-tissue partition and diffusion coefficients
(assuming uniform thiopental concentration in various brain regions). To construct a
complete physiological model of drug distribution this information should be also
available for other organs. Perfusion-limited models of thiopental disposition have been
developed by Price [41] and Saidman and Eger [42].

Although valuable in

understanding the general principles of thiopental distribution, these models never gained
widespread acceptance because of their complexity, arbitrary selection of organ volumes
and flows, and inherent inability to determine partition and diffusion coefficients in
humans.
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An alternative analysis of drug disposition consists of formulating a model containing
the minimum number of compartments that adequately fit the observed data. Although
compartmental analysis gives little insight into the physiological determinants of
phaimacokinetics, these models are widely used in clinical pharmacology and
anesthesiology due to their simplicity and easy experimental verification. A three
compartmental model (e.g. tri-exponential equation) is commonly used to describe the
thiopental concentration-time curve during the first 30 minutes following an intravenous
bolus administration [23,43] and was used in our simulation. The degree of
disequilibrium in drug concentration versus time and effect versus time was evaluated by
adding an effect compartment (biophase) to the three-compartmental model [44]. The
apparent drug concentration at the effect site was calculated using first order kinetics and
plasma concentration predicted by the three-compartmental model. The rate constant of
blood-brain equilibration used in our simulation (k=0.58 mind) was estimated by Stanski
and Maitre [25] from EEG versus thiopental plasma concentration data. We assumed
that cardiovascular and central nervous system effects are kinetically indistinguishable.
Limitations of compartmental analysis in describing early distribution of thiopental
are well recognized [45]. Compartmental kinetics assumes instantaneous mixing of a
drug in the central compartment following intravenous injection. Speed of injection,
however, may influence the drug dose-concentration-effect relationship. Following
intravenous drug administration, the injected bolus travels along the venous vasculature
to the right heart. Using a sheep model, Upton and Huang [461 determined that the
maximum concentration of indocyine green injected into the inferior vena cava occurred
7 to 18 seconds after injection ( injection time 1 to 10 seconds). Although it is possible

to study this delay by introducing an additional central compartment [47], it is unlikely
that a delay of this magnitude will significantly alter model predictions.
There are several other factors that influence thiopental kinetics, which have not as
yet been studied. The effects of disease states, can be simulated by changing intercompartmental and elimination kinetic constants, but were not evaluated. Thiopental
protein-binding and the extent of thiopental ionization are not included in this model.
Thiopental pharmacokinetics determines hemodynamic changes in our model. The
effects of altered hemodynamic parameters on drug distribution cannot be accounted for
by the model in its present form. "Closing the loop" will be an important feature of
future studies.

4.3 Concerning Simulation
Laryngoscopy and endotracheal intubation may elevate systemic pressure and ICP [48,
49]. Although this transient increase is probably unimportant in patients with intact
autoregulation, brain edema and trans-compartmental brain tissue shifts may occur in
patients with already compromised intracranial hemodynamic [50,51]. Our computations
show that a single bolus of thiopental is insufficient to prevent an ICP elevation
associated with

intubation carried out 3 min after thiopental administration.

Cerebrovascular effects of thiopental may be attributed to two basic mechanisms; direct
arteriolar vasoconstriction and reduction of systemic mean arterial pressure [52]. Both
effects are dose-dependent. Rapid redistribution of thiopental decreases its plasma
concentration from 65 ug/mL to 20 ug/mL in 2 minutes. Consequently, systemic arterial
pressure and cerebrovascular conductance rise, negating the initial desirable action of this
drug. If cerebral autoregulation is absent, exaggerated elevation of ICP occurs during
laryngeal stimulation.
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The pattern of ICP and CBF changes produced by our simulation closely resembles
experimental in vivo observations. Shapiro et al. [53] and Greenbaum et al. [54]
demonstrated that patients with preoperative signs of elevated ICP had a significant ICP
increase (30 to 80 mmHg) during intubation using thiopental. Transcranial Doppler
ultrasonography of middle cerebral artery blood flow velocity suggests that hypertensive
responses during laryngoscopy and intubation increase CBF [55,56]. Due to variations in
experimental conditions, the simulated and experimental results can only be compared
qualitatively.
Prevention of hypertensive responses in neurosurgical patients is the subject of
numerous investigations [57-59]. Our computer model looked at the effect of a second
dose of thiopental (4.0 mg/kg) prior to intubation. The simulation shows that this will
attenuate increased ICP and CBF in simulated patients with non-autoregulated cerebral
circulation (Figures 10 and 11). The additional dose of thiopental reduces MAP and
extends the time period of cerebral vasoconstriction.
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Figure 10 Changes in intracranial pressure during induction of anesthesia in a simulated
patient without autoregulation and a second dose of thiopental administered prior to
intubations; A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy begins; and C)
thiopental 4 mg/kg is injected.
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Figure 11 Changes in cerebral blood flow during induction of anesthesia in a simulated
patient without autoregulation and a second dose of thiopental administered prior to
intubation; A) thiopental, 5 mg/kg bolus is injected; B) laryngoscopy begins; and C)
thiopental, 4 mg/kg is injected.

CHAPTER 5

CONCLUSION

The primary purpose of this work is to synthesize cerebrovascular physiology and
pharmacology to allow analysis of complex effects of drugs and mechanical interventions
on CBF and ICP occurring during the administration of anesthetics. The overall model
was constructed from two constituent sub-models: a lumped parameter compartmental
model of intracranial hemodynamics and a pharmacokinetic model of thiopental
distribution. Interaction of the two sub-models was accomplished through concentration
dependent resistance and MAP (mean arterial pressure). The model was tested by
comparing simulation results to available experimental data. Although many aspects of
the mathematical formulation and the values assigned to the variables are controversial,
the important consideration is whether this overall approach is useful to examine the
behavior of the cerebrovascular circulation in vivo. Some merits of our approach are:

1.

We analyzed the effect of autoregulation on intracranial hemodynamics; this can
be extended to examine the effect of brain pathology on the cerebral circulation.
For example, a brain tumor may be modeled by decreasing brain parenchyma
compliance and/or increasing vascular resistance to CSF reabsorption.

2.

The model was used to study responses of the cerebrovascular system to
thiopental and endotracheal intubation. There is no limitation on the variety or
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combination of drugs which can be studied using this model. The relationship
between plasma drug concentration and at least one cerebrovascular parameter
must be available (or derived from the experimental data).

3.

We have examined hemodynamic responses of an intact and compromised
cerebral circulation during the induction of general anesthesia; with appropriate
modifications the model can be used to analyze other clinical situations.

4.

A drug administration regimen which prevents ICP increase associated with
laryngoscopy and intubation was proposed using our model; this can be extended
to develop optimum drug(s) therapy to achieve specific clinical goals. The model
is also useful to conceptualize the problem and examine the interaction between
various parts of the system. Areas that require further studies can be identified as
well.

Cerebrovascular System Model
The appendix contains a listing of the VisSim® code for the Cerebrovascular System Model
developed.

Figure 12 Intracranial hemodynamic compound
block with outputs
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Figure 13 Intracranial hemodynamic compound
block expanded
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Figure 14 Pressure equations compound block
expanded
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Figure 15 Pv cerebral venous pressure compound
block expanded

Figure 16 Pic intracranial pressure compound
block expanded
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Figure 17 Pvs venous sinus pressure compound
block expanded
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Figure 18 Pc cerebral capillary pressure compound
block expanded

37

Figure 19 Par arteriole pressure compound block
expanded
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Figure 20 Conductance equations compound
block expanded
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Figure 21 Gvs hydraulic conductance compound
block expanded

Figure 22 Compliance equations compound block
expanded
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Figure 23 Cai arteriolar compliance compound
block expanded

Figure 24 Cic intracranial compliance compound
block expanded
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Figure 25 Cvi intracranial venous compliance
compound block expanded

Figure 26 CBF equation compound block
expanded
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Figure 27q cerebral blood flow compound block
expanded
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